Response to Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells" [LETTERS TO THE EDITOR]

from The Journal of Immunology current issue https://ift.tt/2GKNuCN